Viewing Study NCT00483860


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-03 @ 10:44 AM
Study NCT ID: NCT00483860
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2007-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Solid tumor, View
None normal renal function View
None renal impairment, View
None prior platinum-based chemotherapy, View